✦ LIBER ✦

Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis

✍ Scribed by Latha Devareddy; Shirin Hooshmand; Julie K. Collins; Edralin A. Lucas; Sheau C. Chai; Bahram H. Arjmandi

Book ID: 108187305
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 224 KB
Volume: 19
Category: Article
ISSN: 0955-2863
DOI: 10.1016/j.jnutbio.2007.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanical Stimulation in the Form of Vi

Mechanical Stimulation in the Form of Vibration Prevents Postmenopausal Bone Loss in Ovariectomized Rats

✍ J. Flieger; Th. Karachalios; L. Khaldi; P. Raptou; G. Lyritis 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 92 KB

Herbal extract prevents bone loss in ova

Herbal extract prevents bone loss in ovariectomized rats

✍ Chungsook Kim; Hyekyung Ha; Je-Hyun Lee; Jin-Sook Kim; Kyeyong Song; Sie Won Par 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 863 KB

Oral Daily Ibandronate Prevents Bone Los

Oral Daily Ibandronate Prevents Bone Loss in Early Postmenopausal Women Without Osteoporosis

✍ Michael R Mcclung; Richard D Wasnich; Robert Recker; Jane A Cauley; Charles H Ch 📂 Article 📅 2003 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 248 KB

Genistein May Prevent Cadmium-Induced Bo

Genistein May Prevent Cadmium-Induced Bone Loss in Ovariectomized Rats

✍ Paik, Min-Kyoung; Lee, Heon-Ok; Chung, Ho-Sam; Yang, Seoung-Oh; Kim, Jae-Hyoun; 📂 Article 📅 2003 🏛 Mary Ann Liebert 🌐 English ⚖ 294 KB

The ovariectomized, mature rat model of

The ovariectomized, mature rat model of postmenopausal osteoporosis: An assessment of the bone sparing effects of curcumin

✍ D.L. French; J.M. Muir; C.E. Webber 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Prevention of bone loss by percutaneous

Prevention of bone loss by percutaneous estradiol implants in ovariectomized rats

✍ Yamamura, Keiko ;Iwata, Hisashi ;Osada, Takashi ;Yano, Kohji ;Yotsuyanagi, Toshi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

This study was conducted to investigate whether hydroxyapatite (HAP) is appropriate as a percutaneous drug carrier for estradiol (E2) for the suppression of bone loss. Tenweek-old female Sprague-Dawley rats were subjected either to bilateral ovariectomy (OVX) or to sham surgery (control). Ovariectom